STOCK TITAN

MapLight Therapeutics officer proposes $7.26M sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

MapLight Therapeutics, Inc. (MPLT) officer Christopher A. Kroeger filed notice of a proposed sale of 236,470 common shares, with an approximate sale date of May 4, 2026 and aggregate market value of $7,259,629.00.

The shares were acquired upon vesting of restricted stock units from July 5, 2024 through April 1, 2026. Sales are to be made pursuant to a previously signed/adopted Rule 10b5-1 selling plan dated December 29, 2025.

The notice also lists sales of 9,135 shares for gross proceeds of $246,020.99 on April 15, 2026, and 10,052 shares for gross proceeds of $275,140.33 on April 16, 2026.

Common shares proposed for sale 236,470 shares Approximate sale date: May 4, 2026
Aggregate market value $7,259,629.00 Securities proposed for sale
Common shares outstanding 42,000,000 shares Reported in securities information
Prior sale 9,135 shares; $246,020.99 gross proceeds April 15, 2026
Prior sale 10,052 shares; $275,140.33 gross proceeds April 16, 2026
Rule 10b5-1 plan adoption date December 29, 2025 Selling plan
Rule 10b5-1 selling plan regulatory
"pursuant to a previously signed/adopted 10b5-1 Selling plan"
restricted stock units financial
"acquired upon the vesting of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Aggregate Market Value financial
"Number of Shares or Other Units To Be Sold | Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MPLT shares did Christopher A. Kroeger propose to sell?

Christopher A. Kroeger, an officer of MapLight Therapeutics, Inc., proposed to sell 236,470 common shares, with an approximate sale date of May 4, 2026. The reported aggregate market value is $7,259,629.00, and sales are to be made under a Rule 10b5-1 selling plan adopted December 29, 2025.

What prior sales by Christopher A. Kroeger does the MPLT notice list?

The notice lists a sale of 9,135 shares for gross proceeds of $246,020.99 on April 15, 2026, and a sale of 10,052 shares for gross proceeds of $275,140.33 on April 16, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading